
Report: HHS Continues to Have Challenges with Cybersecurity in Healthcare
HHS struggles in carrying out its cybersecurity responsibilities, GAO report shows
HHS struggles in carrying out its cybersecurity responsibilities, GAO report shows
Tatiana Fofanova is the CEO of Koda Health. She is dealing with one of the most difficult parts of health care. How do you get patients wishes in the case of end of life or other critical illness made in advance and delivered to medical professionals? Koda Health has not only figured out how to…
Joining Matthew Holt (@boltyboy) on #THCBGang on Thursday November 21 at 1PM PT 4PM ET are regulars delivery & platform expert Vince Kuraitis (@VinceKuraitis) & JL Neptune MD, now at Memora Health, digital health investment banker Steven Wardell (@StevenWardell); and longtime startup and corporate digital health exec Adam Kaufman (@adkaufman) who also writes the Bearing.on…
Kura Oncology already had a broad development plan for ziftomenib in leukemias, but the agreement with Kyowa Kirin provides the cash to execute it and a partner to commercialize the drug globally. Ziftomenib is in the same class of medicines as Syndax Pharmaceuticals’ Revuforj, which won FDA approval last week. The post Kura Oncology Gets…
That is my recent paper with co-authors Shanshan Wang, Jason Shafrin, and Kirk Kerr in BMJ Open. The abstract is below: Objective To estimate the health economic value of postdischarge oral nutrition supplement (ONS) consumption among elderly adults who were malnourished during hospitalisation. Design A cost-effectiveness model was developed from a US payer perspective based on a…
The Commonwealth Fund’s new report examines the facts—and implications—of underinsurance
Nearly a year after the Biden administration gave Florida the green light to become the first state to import lower-cost prescription drugs from Canada — a longtime goal of politicians across the political spectrum, including President-elect Donald Trump — the program has yet to begin. Florida Gov. Ron DeSantis hailed the FDA’s approval of his…
Reducing diagnostic error is a significant part of healthcare organizations’ efforts to improve patient outcomes. By using data to recognize vulnerabilities in the diagnostic process, empowering their diagnostic teams and fostering an environment where every team player understands their vital role organizations can proactively correct the potential root causes of diagnostic errors. The post Strategies…
New advancements can only be fully realized when clinicians, lawmakers, and patients come together. Biomarker tests not only have the potential to improve patient outcomes and address health equity, they can also decrease expenses for financially vulnerable medical systems. The post Eliminating Barriers and Increasing Access to New Testing to Improve Prenatal Care appeared first…
With Donald Trump returning to the presidency and Republican control of the Senate and House, work requirements are likely to be back on the agenda—through federal legislation or Medicaid waivers. This issue brief highlights the history of Medicaid work requirements, describes recent state activity to advance work requirement policies, and recaps the landscape of work…